Skip header and navigation

Refine By

7 records – page 1 of 1.

Association of smoking in adolescence with abdominal obesity in adulthood: a follow-up study of 5 birth cohorts of Finnish twins.

https://arctichealth.org/en/permalink/ahliterature153863
Source
Am J Public Health. 2009 Feb;99(2):348-54
Publication Type
Article
Date
Feb-2009
Author
Suoma E Saarni
Kirsi Pietiläinen
Suvi Kantonen
Aila Rissanen
Jaakko Kaprio
Author Affiliation
Department of Public Health, University of Helsinki, Helsinki, Finland. suoma.saarni@helsinki.fi
Source
Am J Public Health. 2009 Feb;99(2):348-54
Date
Feb-2009
Language
English
Publication Type
Article
Keywords
Abdominal Fat
Adolescent
Adult
Cohort Studies
Female
Finland - epidemiology
Humans
Male
Obesity
Odds Ratio
Overweight - epidemiology
Questionnaires
Smoking - epidemiology
Twin Studies as Topic
Young Adult
Abstract
We studied the association of adolescent smoking with overweight and abdominal obesity in adulthood.
We used the FinnTwin16, a prospective, population-based questionnaire study of 5 consecutive and complete birth cohorts of Finnish twins born between 1975 and 1979 (N = 4296) and studied at four points between the ages of 16 and 27 years to analyze the effect of adolescent smoking on abdominal obesity and overweight in early adulthood.
Smoking at least 10 cigarettes daily when aged 16 to 18 years increased the risk of adult abdominal obesity (odds ratio [OR]=1.77; 95% confidence interval [CI] = 1.39, 2.26). After we adjusted for confounders, the OR was 1.44 (95% CI = 1.11, 1.88), and after further adjustment for current body mass index (BMI), the OR was 1.34 (95% CI = 0.95, 1.88). Adolescent smoking significantly increased the risk of becoming overweight among women even after adjustment for possible confounders, including baseline BMI (OR = 1.74; 95% CI = 1.06, 2.88).
Smoking is a risk factor for abdominal obesity among both genders and for overweight in women. The prevention of smoking during adolescence may play an important role in promoting healthy weight and in decreasing the morbidity related to abdominal obesity.
Notes
Cites: Am J Public Health. 1989 Feb;79(2):152-72913832
Cites: Am J Epidemiol. 1982 Nov;116(5):765-757148802
Cites: Ann Intern Med. 1989 Nov 15;111(10):783-72817625
Cites: JAMA. 1993 Mar 17;269(11):1391-58441214
Cites: BMJ. 1995 Nov 25;311(7017):1401-58520275
Cites: Int J Obes Relat Metab Disord. 1997 Mar;21(3):189-969080257
Cites: J Epidemiol Community Health. 1997 Jun;51(3):252-609229053
Cites: Am J Clin Nutr. 1998 May;67(5):846-529583840
Cites: Int J Obes Relat Metab Disord. 1998 Sep;22(9):915-229756252
Cites: Health Psychol. 1998 Sep;17(5):454-89776004
Cites: J Consult Clin Psychol. 1998 Dec;66(6):987-939874912
Cites: Int J Obes Relat Metab Disord. 1999 Feb;23(2):107-1510078843
Cites: Acta Paediatr. 1999 Apr;88(4):431-710342544
Cites: Int J Obes (Lond). 2005 Feb;29(2):236-4315505632
Cites: Int J Obes (Lond). 2005 Jun;29(6):697-70215782226
Cites: Int J Obes (Lond). 2005 Jul;29(7):778-8415917857
Cites: Eur J Public Health. 2005 Jun;15(3):262-915755781
Cites: Circulation. 2005 Aug 9;112(6):862-916061737
Cites: Obes Res. 2005 Aug;13(8):1466-7516129730
Cites: J Clin Epidemiol. 2005 Nov;58(11):1165-7116223660
Cites: Int J Psychophysiol. 2006 Mar;59(3):236-4316325948
Cites: Nutr Rev. 2006 Feb;64(2 Pt 1):53-6616536182
Cites: Psychosom Med. 2006 May-Jun;68(3):414-2016738073
Cites: Am J Clin Nutr. 2006 Aug;84(2):274-8816895873
Cites: Clin Res Cardiol. 2007 Jun;96(6):365-7417453138
Cites: Am J Public Health. 2007 Aug;97(8):1427-3317600242
Cites: Am J Epidemiol. 2008 Jan 15;167(2):188-9218079134
Cites: Behav Neurosci. 2008 Feb;122(1):161-7318298259
Cites: BMJ. 1989 May 13;298(6683):1287-902500198
Cites: BMJ. 2000 May 6;320(7244):1240-310797032
Cites: Nutrition. 2000 Oct;16(10):924-3611054598
Cites: Am J Med. 2000 Nov;109(7):538-4211063954
Cites: J Epidemiol Community Health. 2002 Mar;56(3):167-7011854334
Cites: Obes Rev. 2001 May;2(2):73-8612119665
Cites: Scand J Med Sci Sports. 2002 Jun;12(3):179-8512135451
Cites: Nat Rev Genet. 2002 Nov;3(11):872-8212415317
Cites: Int J Obes Relat Metab Disord. 2002 Dec;26(12):1570-812461673
Cites: Ann Intern Med. 2003 Jan 7;138(1):24-3212513041
Cites: Twin Res. 2002 Oct;5(5):366-7112537860
Cites: Addict Behav. 2003 Apr;28(3):501-1212628622
Cites: J Adolesc Health. 2003 Apr;32(4):306-1312667735
Cites: Eur J Clin Nutr. 2003 Jul;57(7):842-5312821884
Cites: Twin Res. 2003 Oct;6(5):409-2114624725
Cites: Arch Pediatr Adolesc Med. 2003 Dec;157(12):1212-814662578
Cites: Eur J Clin Nutr. 2004 Jan;58(1):180-9014679384
Cites: JAMA. 2004 Mar 10;291(10):1238-4515010446
Cites: Int J Obes Relat Metab Disord. 2004 Jun;28(6):796-80215024402
Cites: Nicotine Tob Res. 2004 Jun;6(3):397-42515203775
Cites: Int J Obes Relat Metab Disord. 2004 Aug;28(8):1091-615197410
Cites: Am J Clin Nutr. 2004 Sep;80(3):569-7515321794
Cites: Hum Hered. 1978;28(4):241-54566252
Comment In: Am J Public Health. 2009 Aug;99(8):135019542028
PubMed ID
19059868 View in PubMed
Less detail

Associations of Weight Concerns With Self-Efficacy and Motivation to Quit Smoking: A Population-Based Study Among Finnish Daily Smokers.

https://arctichealth.org/en/permalink/ahliterature270690
Source
Nicotine Tob Res. 2015 Sep;17(9):1134-41
Publication Type
Article
Date
Sep-2015
Author
Eeva-Liisa Tuovinen
Suoma E Saarni
Taru H Kinnunen
Ari Haukkala
Pekka Jousilahti
Kristiina Patja
Jaakko Kaprio
Tellervo Korhonen
Source
Nicotine Tob Res. 2015 Sep;17(9):1134-41
Date
Sep-2015
Language
English
Publication Type
Article
Keywords
Adult
Aged
Body mass index
Cotinine - blood
Cross-Sectional Studies
Female
Finland
Humans
Male
Middle Aged
Motivation
Self Efficacy
Self Report
Smoking - psychology
Smoking Cessation - psychology
Tobacco Use Disorder - psychology
Weight Gain
Abstract
Concerns about weight gain occurring after smoking cessation may affect motivation and self-efficacy towards quitting smoking. We examined associations of smoking-specific weight concerns with smoking cessation motivation and self-efficacy in a population-based cross-sectional sample of daily smokers.
Six-hundred biochemically verified (blood cotinine) current daily smokers comprising 318 men and 282 women aged 25-74 years, were studied as part of the National FINRISK (Finnish Population Survey on Risk Factors on Chronic, Noncommunicable Diseases) study and its DIetary, Lifestyle and Genetic factors in the development of Obesity and Metabolic syndrome (DILGOM) sub-study that was conducted in Finland in 2007. Self-reported scales were used to assess weight concerns, motivation and self-efficacy regarding the cessation of smoking. Multiple regression analyses of concerns about weight in relation to motivation and self-efficacy were conducted with adjustments for sex, age (years), body mass index (BMI, [kg/m(2)]), physical activity (times per week), and further controlled for nicotine dependence (Fagerström Test for Nicotine Dependence).
Higher levels of weight concerns were associated with lower self-efficacy (ß = -0.07, p
PubMed ID
25542916 View in PubMed
Less detail

Dietary and lifestyle characteristics associated with normal-weight obesity: the National FINRISK 2007 Study.

https://arctichealth.org/en/permalink/ahliterature106164
Source
Br J Nutr. 2014 Mar 14;111(5):887-94
Publication Type
Article
Date
Mar-14-2014
Author
Satu Männistö
Kennet Harald
Jukka Kontto
Marjaana Lahti-Koski
Niina E Kaartinen
Suoma E Saarni
Noora Kanerva
Pekka Jousilahti
Author Affiliation
Department of Chronic Disease Prevention, National Institute for Health and Welfare, PO Box 30, 00271, Helsinki, Finland.
Source
Br J Nutr. 2014 Mar 14;111(5):887-94
Date
Mar-14-2014
Language
English
Publication Type
Article
Keywords
Adipose Tissue - pathology
Adiposity
Adult
Aged
Alcohol Drinking - adverse effects
Body mass index
Cohort Studies
Cross-Sectional Studies
Diet - adverse effects
Female
Finland - epidemiology
Humans
Life Style
Male
Middle Aged
Nutrition Surveys
Obesity - epidemiology - etiology - pathology
Overweight - epidemiology - etiology - pathology
Prevalence
Risk factors
Sedentary lifestyle
Smoking - adverse effects
Abstract
The aim of the present study was to compare the lifestyle (leisure-time physical activity, smoking habits and alcohol consumption) and dietary (energy-yielding nutrients, dietary fibre and foods) factors of Finns with a new syndrome called normal-weight obesity (NWO) with those of lean and overweight Finns. The representative population-based study included 4786 participants (25-74 years) from the National FINRISK 2007 Study with a health examination and questionnaires. Food intake was assessed using a validated FFQ. NWO was defined to include those with a normal BMI (
PubMed ID
24229475 View in PubMed
Less detail

The effect of alcohol consumption on later obesity in early adulthood--a population-based longitudinal study.

https://arctichealth.org/en/permalink/ahliterature146090
Source
Alcohol Alcohol. 2010 Mar-Apr;45(2):173-9
Publication Type
Article
Author
Matti Pajari
Kirsi H Pietiläinen
Jaakko Kaprio
Richard J Rose
Suoma E Saarni
Author Affiliation
Department of Public Health, University of Helsinki, PO Box 14, 00014 Helsinki, Finland.
Source
Alcohol Alcohol. 2010 Mar-Apr;45(2):173-9
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Age of Onset
Alcohol Drinking - adverse effects - epidemiology
Body mass index
Female
Finland
Health Surveys
Humans
Longitudinal Studies
Male
Obesity - epidemiology
Obesity, Abdominal - epidemiology
Risk factors
Temperance - statistics & numerical data
Waist Circumference
Young Adult
Abstract
The study aimed to determine whether alcohol use during late adolescence contributes to the weight gain from adolescence to young adulthood or risk of obesity or waist circumference at young adulthood.
A population-based, longitudinal study of 5563 Finnish twins born in 1975-1979 and surveyed at ages 16 (T1), 17 (T2), 18 (T3) and 23-27 (T4) years. Drinking habits, height and weight were self-reported at T1, T2, T3 and T4; waist circumference was self-measured at T4. As potential confounders, we used smoking, diet, physical activity, place of residence, socio-economic status and parents' body mass index (BMI).
Compared to the reference group (drinking once to twice per month), the BMI increase from T3 to T4 was less among abstaining men (-0.62 kg/m(2), (95% CI -1.04, -0.20)) and among women in those drinking less than monthly (-0.38 kg/m(2), (-0.71, -0.04)). In women, at least weekly drinking was associated with larger waist circumference (Beta 1.55 cm, (0.48, 2.61)), but this became statistically non-significant after adjusting for potential confounders. In a multilevel model for change, drinking frequency was not associated with weight change in women; in men, a negative association was seen, but it was statistically non-significant after adjusting for potential confounders.
These results from a population-based study with a large set of confounding variables suggest that alcohol use during adolescence has at most a minor effect on weight gain or development of abdominal obesity from adolescence to young adulthood.
Notes
Cites: Scand J Med Sci Sports. 2002 Jun;12(3):179-8512135451
Cites: Alcohol Alcohol. 2002 Jul-Aug;37(4):330-912107034
Cites: Int J Obes Relat Metab Disord. 2003 Sep;27(9):1081-612917714
Cites: Eur J Clin Nutr. 2004 Jan;58(1):180-9014679384
Cites: Soc Sci Med. 1995 Jul;41(1):113-217667664
Cites: BMJ. 1995 Oct 14;311(7011):986-97580640
Cites: Addiction. 1996 Sep;91(9):1345-578854370
Cites: Am J Clin Nutr. 1999 Feb;69(2):205-129989681
Cites: Public Health Nutr. 2005 May;8(3):315-2015918929
Cites: Crit Rev Clin Lab Sci. 2005;42(3):197-22716047538
Cites: Duodecim. 2005;121(18):1925-716300306
Cites: Am J Clin Nutr. 2006 Aug;84(2):274-8816895873
Cites: Twin Res Hum Genet. 2006 Dec;9(6):772-717254406
Cites: Arch Pediatr Adolesc Med. 2007 Oct;161(10):959-6617909139
Cites: J Clin Endocrinol Metab. 2008 Jan;93(1):154-6118029458
Cites: Obesity (Silver Spring). 2008 Feb;16(2):409-1418239652
Cites: Behav Neurosci. 2008 Feb;122(1):161-7318298259
Cites: Obesity (Silver Spring). 2008 Jul;16(7):1718-2218451778
Cites: Am J Public Health. 2009 Feb;99(2):348-5419059868
Cites: JAMA. 2009 Jan 21;301(3):318-2019155459
Cites: Addiction. 2009 Sep;104(9):1487-50019686518
Cites: J Stud Alcohol. 2004 Mar;65(2):204-1215151351
Cites: Br J Addict. 1988 Sep;83(9):1019-303066418
Cites: BMJ. 2000 May 6;320(7244):1240-310797032
Cites: Health Educ Res. 2000 Jun;15(3):261-910977374
Cites: Addiction. 2000 Aug;95(8):1255-6311092073
Cites: Int J Obes Relat Metab Disord. 2001 Feb;25(2):147-5711410813
Cites: Eur J Clin Nutr. 2003 Jul;57(7):842-5312821884
PubMed ID
20071348 View in PubMed
Less detail

Mortality and its determinants in people with psychotic disorder.

https://arctichealth.org/en/permalink/ahliterature117876
Source
Psychosom Med. 2013 Jan;75(1):60-7
Publication Type
Article
Date
Jan-2013
Author
Jaana Suvisaari
Krista Partti
Jonna Perälä
Satu Viertiö
Suoma E Saarni
Jouko Lönnqvist
Samuli I Saarni
Tommi Härkänen
Author Affiliation
Department of Mental Health and Substance Abuse Services, National Institute forHealth and Welfare, Helsinki, Finland. jaana.suvisaari@thl.fi
Source
Psychosom Med. 2013 Jan;75(1):60-7
Date
Jan-2013
Language
English
Publication Type
Article
Keywords
Adult
Affective Disorders, Psychotic - drug therapy - mortality
Antipsychotic Agents - therapeutic use
Cohort Studies
Diabetes Mellitus, Type 2 - mortality
Female
Finland - epidemiology
Follow-Up Studies
Health Surveys
Humans
Male
Middle Aged
Proportional Hazards Models
Prospective Studies
Psychotic Disorders - drug therapy - mortality
Risk factors
Schizophrenia - drug therapy - mortality
Smoking - mortality
Abstract
We investigated mortality and its determinants in people with psychotic disorder.
A nationally representative two-stage cluster sample of 8028 persons aged 30 years or older from Finland was selected for a comprehensive health survey conducted from 2000 to 2001. Participants were screened for psychotic disorder, and screen-positive persons were invited for a Structured Clinical Interview for DSM-IV. The diagnostic assessment of DSM-IV psychotic disorders was based on the Structured Clinical Interview for DSM-IV, case records from mental health treatments, or both. Mortality was followed up until September 2009 and analyzed using Cox proportional hazards model.
People with schizophrenia (hazard ratio [HR] = 3.03; 95% confidence interval [CI] = 1.93-4.77) and other nonaffective psychoses (HR = 1.84; 95% CI = 1.17-2.91) had elevated mortality risk, whereas people with affective psychoses did not (HR = 0.61; 95% CI = 0.24-1.55). Antipsychotic medication use was associated with increased mortality (HR = 2.34; 95% CI = 1.86-2.96). There was an interaction between antipsychotic medication use and the presence of a psychotic disorder: antipsychotic medication use was only associated with elevated mortality in persons who were using antipsychotics and did not have primary psychotic disorder. In persons with psychotic disorder, mortality was predicted by smoking and Type 2 diabetes at baseline survey.
Schizophrenia and nonaffective psychoses are associated with increased mortality risk, whereas affective psychoses are not. Antipsychotic medication use increases mortality risk in older people without primary psychotic disorder, but not in individuals with schizophrenia. Smoking and Type 2 diabetes are important predictors of elevated mortality risk in persons with psychotic disorder.
PubMed ID
23257931 View in PubMed
Less detail

Recurrent dieting and smoking among Finnish men and women.

https://arctichealth.org/en/permalink/ahliterature162425
Source
Obesity (Silver Spring). 2007 Jul;15(7):1851-9
Publication Type
Article
Date
Jul-2007
Author
Suoma E Saarni
Karri Silventoinen
Aila Rissanen
Sirpa Sarlio-Lähteenkorva
Jaakko Kaprio
Author Affiliation
Department of Public Health, PO Box 41, University of Helsinki, and Department of Psychiatry, Helsinki University Hospital, Finland. suoma.saarni@helsinki.fi
Source
Obesity (Silver Spring). 2007 Jul;15(7):1851-9
Date
Jul-2007
Language
English
Publication Type
Article
Keywords
Adult
Body Weight
Cohort Studies
Diet, Reducing - statistics & numerical data
Educational Status
Female
Finland - epidemiology
Humans
Male
Middle Aged
Questionnaires
Recurrence
Regression Analysis
Smoking - epidemiology
Abstract
To examine the association of smoking with recurrent dieting and BMI among Finnish adults.
We used questionnaire data from 1990 on 11,055 subjects from the Finnish Twin Cohort who were 33 to 61 years of age. Multinomial logistic regression analysis was carried out using lifetime dieting as the outcome variable and smoking as the main explanatory variable, adjusted for BMI and age. Twin pairs discordant for dieting and smoking were studied to examine the effect of environmental and genetic factors.
Among women, current smokers [odds ratio (OR), 1.09 to 1.41 at different ages] and former smokers (OR, 1.52 to 2.82) were more likely to have dieted recurrently than never smokers. Among men, current smokers were less likely (OR, 0.69; 95% confidence interval, 0.55, 0.87) and former smokers were more likely (OR, 1.30; 95% confidence interval, 1.05, 1.61) to have dieted recurrently at different ages. The differences between the discordant pairs were consistent with this, although not statistically significant.
Recurrent dieting was associated with former smoking in both sexes and with current smoking in women.
PubMed ID
17636104 View in PubMed
Less detail

Validation of the Finnish version of the SCOFF questionnaire among young adults aged 20 to 35 years.

https://arctichealth.org/en/permalink/ahliterature152739
Source
BMC Psychiatry. 2009;9:5
Publication Type
Article
Date
2009
Author
Sini Lähteenmäki
Terhi Aalto-Setälä
Jaana T Suokas
Suoma E Saarni
Jonna Perälä
Samuli I Saarni
Hillevi Aro
Jouko Lönnqvist
Jaana M Suvisaari
Author Affiliation
Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland. sini.lahteenmaki@helsinki.fi
Source
BMC Psychiatry. 2009;9:5
Date
2009
Language
English
Publication Type
Article
Keywords
Adult
Eating Disorders - diagnosis
Female
Finland
Humans
Male
Psychiatric Status Rating Scales
Questionnaires
Sensitivity and specificity
Young Adult
Abstract
We tested the validity of the SCOFF, a five-question screening instrument for eating disorders, in a general population sample.
A random sample of 1863 Finnish young adults was approached with a questionnaire that contained several screens for mental health interview, including the SCOFF. The questionnaire was returned by 1316 persons. All screen positives and a random sample of screen negatives were invited to SCID interview. Altogether 541 subjects participated in the SCID interview and had filled in the SCOFF questionnaire. We investigated the validity of the SCOFF in detecting current eating disorders by calculating sensitivity, specificity, and positive and negative predictive values (PPV and NPV) for different cut-off scores. We also performed a ROC analysis based on these 541 persons, of whom nine had current eating disorder.
The threshold of two positive answers presented the best ability to detect eating disorders, with a sensitivity of 77.8%, a specificity of 87.6%, a PPV of 9.7%, and a NPV of 99.6%. None of the subjects with current eating disorder scored zero points in the SCOFF.
Due to its low PPV, there are limitations in using the SCOFF as a screening instrument in unselected population samples. However, it might be used for ruling out the possibility of eating disorders.
Notes
Cites: J Psychosom Res. 2005 Aug;59(2):51-516185998
Cites: Eat Weight Disord. 2005 Jun;10(2):76-8216114220
Cites: Curr Opin Psychiatry. 2006 Jul;19(4):389-9416721169
Cites: Biol Psychiatry. 2007 Feb 1;61(3):348-5816815322
Cites: Am J Psychiatry. 2007 Aug;164(8):1259-6517671290
Cites: Behav Res Ther. 2008 May;46(5):612-2218359005
Cites: J Affect Disord. 2008 Sep;110(1-2):36-4518279972
Cites: Psychol Med. 2009 Feb;39(2):287-9918507875
Cites: BMJ. 1999 Dec 4;319(7223):1467-810582927
Cites: Psychol Assess. 2000 Jun;12(2):123-3110887758
Cites: Am J Psychiatry. 2000 Nov;157(11):1873-511058490
Cites: Am J Psychiatry. 2002 Aug;159(8):1284-9312153817
Cites: BMJ. 2002 Oct 5;325(7367):755-612364305
Cites: Int J Eat Disord. 2002 Dec;32(4):466-7212386911
Cites: J Gen Intern Med. 2003 Jan;18(1):53-612534764
Cites: Arch Gen Psychiatry. 2003 Feb;60(2):184-912578436
Cites: Behav Res Ther. 2004 May;42(5):551-6715033501
Cites: Eur J Clin Nutr. 2004 Jun;58(6):846-5215164104
Cites: Int J Eat Disord. 2004 Nov;36(3):280-9515478137
Cites: Psychol Med. 1979 May;9(2):273-9472072
Cites: JAMA. 1984 Oct 12;252(14):1905-76471323
Cites: Br J Psychiatry. 1987 Jan;150:18-243651670
Cites: Arch Gen Psychiatry. 1989 Jul;46(7):664-72735814
Cites: Int J Eat Disord. 1996 Jul;20(1):57-648807353
Cites: Psychiatr Clin North Am. 1996 Dec;19(4):681-7008933602
Cites: Psychol Med. 1997 Jan;27(1):191-79122299
Cites: Scand J Clin Lab Invest Suppl. 1997;227:46-639127468
Cites: Int J Eat Disord. 1997 Jul;22(1):89-939140741
Cites: Acta Psychiatr Scand. 1999 Apr;99(4):261-610223428
Cites: Soc Psychiatry Psychiatr Epidemiol. 2005 Jan;40(1):1-1015624068
Cites: Aten Primaria. 2005 Feb 15;35(2):89-9415727751
Cites: Eur J Clin Nutr. 2005 Mar;59(3):459-6215674311
Cites: Biomedica. 2005 Jun;25(2):196-20216022374
Cites: J Am Coll Health. 2005 Sep-Oct;54(2):103-716255322
PubMed ID
19200401 View in PubMed
Less detail

7 records – page 1 of 1.